Clinical TrialsSearch results
Number of results: 528
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Accelerated fractionation vs. conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 Phase III study (JCOG0701)
- T1-2N0M0 glottic cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-09-05
Other
- Accelerative effect of polaprezinc on healing gastric ulcer after eradication of Helicobacter pylori infection
- Gastric ulcer with Helicobacter pylori infection
- Zeria Pharmaceutical Co.,LTD.
- 2005-09-13
Other
- Additional JET Study for Patients during Maintenance Phase(Co-JET Study)
- maintenance-phase renal failure (predialysis renal failure)
- Scientific Advisory Committee (SAC)
- 2005-10-01
Other
- Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT)
- Diabetic peripheral neuropathy
- The Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT) Study Group
- 2007-02-20
Other
- An exploratory research for a case with peripheral artery disease as a complication of lumbar spinal canal stenosis.
- lumbar spinal canal stenosis
- Fukushima medical university school of medicine
- 2008-12-05
Recruiting
- An investigational study of chemoradiosensitivity prediction with genetic profiling of esophageal biopsy for squamous cell carcinoma of the esophagus
- Esophageal cancer
- University of Toyama
- 2007-02-01
Recruiting
- An Investigator-initiated Clinical Trial, First in Human study, wi th a natural-type micro RNA MIRX002, for patients with malignant pleural mesothelioma (MIRX002-01 repeated dose study)
- Malignant pleural mesothelioma
- Morihito Okada
- 2022-05-11
Recruiting
- An Investigator-initiated Clinical Trial, First in Human study, with a natural-type micro RNA MIRX002, for patients with malignant pleural mesothelioma
- Malignant pleural mesothelioma
- Okada Morihito
- 2021-12-09
Other
- An observational study in patients who received nivolumab preoperatively for stage 1 non-small cell lung cancer considered as high-risk of relapse
- non small cell lung cancer
- Okada Morihito
- 2019-06-18